ImmunoPrecise Antibodies Ltd (IPA)
1.28
+0.02
(+1.59%)
USD |
NASDAQ |
May 03, 16:00
1.26
-0.02
(-1.56%)
After-Hours: 20:00
ImmunoPrecise Antibodies Net Income (TTM): -10.56M for Jan. 31, 2024
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| January 31, 2024 | -10.56M |
| October 31, 2023 | -11.87M |
| July 31, 2023 | -15.46M |
| April 30, 2023 | -20.07M |
| January 31, 2023 | -19.95M |
| October 31, 2022 | -19.49M |
| July 31, 2022 | -17.95M |
| April 30, 2022 | -13.29M |
| January 31, 2022 | -13.63M |
| October 31, 2021 | -11.61M |
| July 31, 2021 | -7.980M |
| April 30, 2021 | -5.753M |
| January 31, 2021 | -2.446M |
| October 31, 2020 | -1.916M |
| July 31, 2020 | -2.595M |
| April 30, 2020 | -3.708M |
| January 31, 2020 | -5.905M |
| October 31, 2019 | -6.321M |
| July 31, 2019 | -6.430M |
| April 30, 2019 | -5.761M |
| January 31, 2019 | -4.602M |
| October 31, 2018 | -4.669M |
| July 31, 2018 | -4.251M |
| April 30, 2018 | -4.055M |
| January 31, 2018 | -3.228M |
| Date | Value |
|---|---|
| October 31, 2017 | -5.598M |
| July 31, 2017 | -4.879M |
| April 30, 2017 | -4.237M |
| January 31, 2017 | -3.341M |
| September 30, 2016 | -0.0437M |
| June 30, 2016 | -0.0424M |
| March 31, 2016 | -0.0285M |
| December 31, 2015 | -0.0232M |
| September 30, 2015 | -0.007M |
| June 30, 2015 | -0.0317M |
| March 31, 2015 | -0.0371M |
| December 31, 2014 | -0.0564M |
| September 30, 2014 | -0.0864M |
| June 30, 2014 | 0.0806M |
| March 31, 2014 | 0.0671M |
| December 31, 2013 | 0.0666M |
| September 30, 2013 | 0.0468M |
| June 30, 2013 | -0.1108M |
| March 31, 2013 | -0.1001M |
| December 31, 2012 | -0.0963M |
| September 30, 2012 | -0.1479M |
| June 30, 2012 | -0.195M |
| March 31, 2012 | -0.2564M |
| December 31, 2011 | -0.2794M |
| September 30, 2011 | -5.215M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (TTM) Range, Past 5 Years
-20.07M
Minimum
Apr 2023
-1.916M
Maximum
Oct 2020
-10.36M
Average
-10.56M
Median
Jan 2024
Net Income (TTM) Benchmarks
| Acasti Pharma Inc | -38.77M |
| Aurinia Pharmaceuticals Inc | -78.02M |
| Edesa Biotech Inc | -7.718M |
| Lexaria Bioscience Corp | -5.440M |
| Xenon Pharmaceuticals Inc | -182.39M |